Angela Mastronuzzi, Head of Neuro-Oncology Unit at Bambino Gesù Children’s Hospital and President of AIEOP, shared a post on LinkedIn:
“Yesterday, I had the privilege of speaking at the ESMO – European Society for Medical Oncology’s Sarcoma and Rare Cancers Congress 2026 in Lugano, Switzerland.
During a Multidisciplinary Tumor Board, I discussed the management of Neurofibromatosis Type 1 (NF1)-related CNS tumors with Enrico Franceschi.
The board also explored important topics such as:
– Case presentations
– NF1 surveillance guidelines
– Supporting survivors of childhood NF1-associated glioma during transition in neuro-oncology
And I had the opportunity to speak specifically on “Diagnosis and treatment of NF1-associated glioma.”
The congress provided a comprehensive overview of the latest advances in rare solid tumors, from diagnosis and molecular insights to treatment strategies, highlighting the evolving landscape of these complex diseases.”
Other articles from ESMO Sarcoma and Rare Cancers Congress 2026 on OncoDaily.
